Home/Filings/4/0001415889-22-006712
4//SEC Filing

KELER TIBOR 4

Accession 0001415889-22-006712

CIK 0000744218other

Filed

Jun 16, 8:00 PM ET

Accepted

Jun 17, 4:11 PM ET

Size

5.7 KB

Accession

0001415889-22-006712

Insider Transaction Report

Form 4
Period: 2022-06-16
KELER TIBOR
Sr. VP & CSO
Transactions
  • Award

    Incentive Stock Option (right to buy)

    2022-06-16+91,00091,000 total
    Exercise: $22.48From: 2023-06-16Exp: 2032-06-16Common Stock (91,000 underlying)
Footnotes (2)
  • [F1]Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.
  • [F2]25% vest on June 16, 2023 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.

Issuer

Celldex Therapeutics, Inc.

CIK 0000744218

Entity typeother

Related Parties

1
  • filerCIK 0001429931

Filing Metadata

Form type
4
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:11 PM ET
Size
5.7 KB